Eva Rodríguez

597 total citations
23 papers, 467 citations indexed

About

Eva Rodríguez is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Eva Rodríguez has authored 23 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 13 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Eva Rodríguez's work include Neuroblastoma Research and Treatments (16 papers), Erythrocyte Function and Pathophysiology (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Eva Rodríguez is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Erythrocyte Function and Pathophysiology (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Eva Rodríguez collaborates with scholars based in Spain, United States and Argentina. Eva Rodríguez's co-authors include Jaume Mora, Carmen de Torres, Cinzia Lavarino, Idoia García, Mariona Suñol, Patricia Galván, José Ríos, Sandra Acosta, Enrique de Álava and Nai‐Kong V. Cheung and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Cancer Research.

In The Last Decade

Eva Rodríguez

22 papers receiving 460 citations

Peers

Eva Rodríguez

NEURO

ONCOL

PRM

Vandana Batra United States

Jinhua Cui United States

Britt Hanson United Kingdom

Virginia Di Paolo Italy

Anneleen Beckers Belgium

Céline Villenet France

Hiromu Yano Japan

Hiranmayi Ravichandran United States

Laura S. Danielson United States

Elham Roshandel Iran

Vandana Batra United States

Eva Rodríguez

139 ×0.5

189 ×0.9

NEURO

85 ×0.9

89 ×1.2

ONCOL

82 ×1.6

PRM

Citations per year, relative to Eva Rodríguez Eva Rodríguez (= 1×) peers Vandana Batra

Countries citing papers authored by Eva Rodríguez

Since Specialization

Citations

This map shows the geographic impact of Eva Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rodríguez more than expected).

Fields of papers citing papers by Eva Rodríguez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rodríguez. The network helps show where Eva Rodríguez may publish in the future.

Co-authorship network of co-authors of Eva Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Rodríguez. A scholar is included among the top collaborators of Eva Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Rodríguez. Eva Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paco, Sonia, Federica Zito Marino, Eva Rodríguez, et al.. (2025). Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma. Neuro-Oncology Advances. 7(1). vdaf132–vdaf132.

Olaciregui, Nagore G., Sonia Paco, Eva Rodríguez, et al.. (2025). Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas. Journal of Neuro-Oncology. 172(3). 599–611. 3 indexed citations

Castillo‐Ecija, Helena, Eva Rodríguez, Sara Pérez‐Jaume, et al.. (2023). Prognostic value of xenograft engraftment in patients with metastatic high‐risk neuroblastoma. Pediatric Blood & Cancer. 70(6). e30318–e30318. 2 indexed citations

Pascual‐Pasto, Guillem, Nagore G. Olaciregui, Mònica Vilà-Ubach, et al.. (2016). Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination. Cancer Letters. 380(1). 10–19. 24 indexed citations

Mateo‐Lozano, Silvia, Marta García, Eva Rodríguez, et al.. (2016). Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens. Oncotarget. 7(13). 16112–16129. 18 indexed citations

Paco, Sonia, Mònica Vilà-Ubach, Eva Rodríguez, et al.. (2015). Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts. Pharmaceutical Research. 32(9). 2889–2900. 9 indexed citations

Jové, Maria, Jaume Mora, Eva Rodríguez, et al.. (2014). Simultaneous KIT mutation and succinate dehydrogenase (SDH) deficiency in a patient with a gastrointestinal stromal tumour and Carney‐Stratakis syndrome: a case report. Histopathology. 65(5). 712–717. 7 indexed citations

Masvidal, Laìa, Raquel Revuelta Iniesta, Patricia Galván, et al.. (2013). Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma. PLoS ONE. 8(3). e59762–e59762. 11 indexed citations

García, Idoia, José Ríos, Gema Doménech, et al.. (2012). A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clinical Cancer Research. 18(7). 2012–2023. 51 indexed citations

10.

Ordóñez, José Luis, Eva Rodríguez, Patricia Galván, et al.. (2012). The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. Carcinogenesis. 34(2). 268–276. 33 indexed citations

11.

Martı́n-Subero, José I., José Ríos, Ana C. Queirós, et al.. (2012). DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis. PLoS ONE. 7(11). e48401–e48401. 30 indexed citations

12.

Mora, Jaume, Eva Rodríguez, Carmen de Torres, et al.. (2011). Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome. Pediatric Blood & Cancer. 58(4). 532–538. 26 indexed citations

13.

Mora, Jaume, Carmen de Torres, Andreu Parareda, et al.. (2011). Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents. Pediatric Blood & Cancer. 57(1). 69–75. 11 indexed citations

14.

Acosta, Sandra, Eva Rodríguez, Cinzia Lavarino, et al.. (2011). Identification of tumoral glial precursor cells in neuroblastoma. Cancer Letters. 312(1). 73–81. 11 indexed citations

15.

García, Idoia, Eva Rodríguez, Mariona Suñol, et al.. (2010). Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Molecular Cancer. 9(1). 277–277. 52 indexed citations

16.

Acosta, Sandra, Cinzia Lavarino, Raquel Parı́s, et al.. (2009). Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells. BMC Developmental Biology. 9(1). 12–12. 49 indexed citations

17.

Torres, Carmen de, Rubén Díaz, Núria Torán, et al.. (2009). The calcium‐sensing receptor and parathyroid hormone‐related protein are expressed in differentiated, favorable neuroblastic tumors. Cancer. 115(12). 2792–2803. 24 indexed citations

18.

Lavarino, Cinzia, Idoia García, Carlos Mackintosh, et al.. (2008). Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status. BMC Medical Genomics. 1(1). 36–36. 10 indexed citations

19.

Negredo, Eugènia, José Moltó, José A. Muñoz-Moreno, et al.. (2004). Safety and Efficacy of Once-Daily Didanosine, Tenofovir and Nevirapine as a Simplification Antiretroviral Approach. Antiviral Therapy. 9(3). 335–342. 39 indexed citations

20.

Rodríguez, Eva, María Teresa Parra, Julio S. Rufas, & José Á. Suja. (2001). Colchicine promotes a change in chromosome structure without loss of sister chromatid cohesion in prometaphase I-arrested bivalents. Chromosoma. 110(7). 478–486. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact